Package 0115-6811-08

{"route": ["ORAL"], "spl_id": "5fb023e1-b35a-40c0-a5aa-1e383dcd4d86", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["fddc9630-2f9a-4104-888f-3714587d4fe7"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-02)", "package_ndc": "0115-6811-02", "marketing_start_date": "20090501"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-08)", "package_ndc": "0115-6811-08", "marketing_start_date": "20090501"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-10)", "package_ndc": "0115-6811-10", "marketing_start_date": "20090501"}], "brand_name": "Bupropion Hydrochloride", "product_id": "0115-6811_5fb023e1-b35a-40c0-a5aa-1e383dcd4d86", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0115-6811", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA077415", "marketing_category": "ANDA", "marketing_start_date": "20090501", "listing_expiration_date": "20261231"}